Evidence map›Paper›PMID 37259403›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Fabrication of Celecoxib PVP Microparticles Stabilized by Gelucire 48/16 via Electrospraying for Enhanced Anti-Inflammatory Action.

Samar Zuhair Alshawwa, Thanaa A El-Masry, Engy Elekhnawy, Hadil Faris Alotaibi, Al-Sayed Sallam, Dalia H Abdelkader

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Samar Zuhair AlshawwaDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0001-9232-7956
Thanaa A El-MasryPharmacology and Toxicology Department, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.
Engy ElekhnawyPharmaceutical Microbiology Department, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.ORCID 0000-0001-8287-1026
Hadil Faris AlotaibiDepartment of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia.ORCID 0000-0003-2821-9373
Al-Sayed SallamAl-Taqaddom Pharmaceutical Industries, Amman 11947, Jordan.ORCID 0000-0002-7872-2084
Dalia H AbdelkaderPharmaceutical Technology Department, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt.ORCID 0000-0002-6277-3565

Funding

Princess Nourah bint Abdulrahman University FRP-1441-14
6 · The paper itself

Abstract

Electrospraying (ES) technology is considered an efficient micro/nanoparticle fabrication technique with controlled dimensions and diverse morphology. Gelurice

Indexed as

carrageenan-induced inflammationcyclooxygenase 2electrosprayingenhanced oral bioavailabilitygene expressionmicellar solubilizationproinflammatory cytokine

Identifiers

PMID37259403
PMCPMC9960083

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.